Evaluation of superoxide dismutase from Helicobacter pylori as a protective vaccine antigen. (Q54373792)

28 May 2018

title

Evaluation of superoxide dismutase from Helicobacter pylori as a protective vaccine antigen. (English)

1 reference

28 May 2018

0 references

1

1 reference

28 May 2018

Garrett Z. Ng

4

1 reference

28 May 2018

Philip Sutton

7

1 reference

28 May 2018

Andrew Stent

object named as

Andrew Stent

2

0 references

author name string

Margaret B Moloney

3

1 reference

28 May 2018

Caroline D Skene

5

1 reference

28 May 2018

Stirling J Edwards

6

1 reference

28 May 2018

language of work or name

English

0 references

publication date

18 December 2010

1 reference

28 May 2018

published in

Vaccine

1 reference

28 May 2018

volume

29

1 reference

28 May 2018

issue

7

1 reference

28 May 2018

page(s)

1514-1518

1 reference

28 May 2018

Helicobacter pylori infection: a clinical overview

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.019

Production of reactive oxygen species by gastric cells in association with Helicobacter pylori

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.019

Helicobacter pylori induces but survives the extracellular release of oxygen radicals from professional phagocytes using its catalase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.019

Helicobacter pylori disrupts NADPH oxidase targeting in human neutrophils to induce extracellular superoxide release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.019

Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.019

Iron-responsive regulation of the Helicobacter pylori iron-cofactored superoxide dismutase SodB is mediated by Fur

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.019

The diverse antioxidant systems of Helicobacter pylori

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.019

Superoxide dismutase-deficient mutants of Helicobacter pylori are hypersensitive to oxidative stress and defective in host colonization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.019

A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.019

Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.019

Further development of the Helicobacter pylori mouse vaccination model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.019

Systemic immunization with unadjuvanted whole Helicobacter pylori protects mice against heterologous challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.019

Evaluation of ISCOMATRIX and ISCOM vaccines for immunisation against Helicobacter pylori

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.019

Considering increased mouse stomach mass when calculating prophylactic vaccine efficacy against Helicobacter pylori

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.019

New concepts of resistance in the treatment of Helicobacter pylori infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.019

Catalase (KatA) and KatA-associated protein (KapA) are essential to persistent colonization in the Helicobacter pylori SS1 mouse model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.019

Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.019

Effectiveness of vaccination with recombinant HpaA from Helicobacter pylori is influenced by host genetic background

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.019

The GroES homolog of Helicobacter pylori confers protective immunity against mucosal infection in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.019

Regulation of superoxide dismutase genes: implications in disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.019

Catalase, a novel antigen for Helicobacter pylori vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.019

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2010.12.019

1 reference

28 May 2018

1 reference

28 May 2018